Details for New Drug Application (NDA): 050141
✉ Email this page to a colleague
NDA 050141 describes BICILLIN L-A, which is a drug marketed by King Pharms Llc and Wyeth Ayerst and is included in two NDAs. It is available from two suppliers. Additional details are available on the BICILLIN L-A profile page.
The generic ingredient in BICILLIN L-A is penicillin g benzathine. There are ninety-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the penicillin g benzathine profile page.
The generic ingredient in BICILLIN L-A is penicillin g benzathine. There are ninety-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the penicillin g benzathine profile page.
Summary for 050141
| Tradename: | BICILLIN L-A |
| Applicant: | King Pharms Llc |
| Ingredient: | penicillin g benzathine |
| Patents: | 0 |
Suppliers and Packaging for NDA: 050141
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BICILLIN L-A | penicillin g benzathine | INJECTABLE;INJECTION | 050141 | NDA | A-S Medication Solutions | 50090-1016 | 50090-1016-0 | 10 SYRINGE in 1 PACKAGE (50090-1016-0) / 2 mL in 1 SYRINGE |
| BICILLIN L-A | penicillin g benzathine | INJECTABLE;INJECTION | 050141 | NDA | A-S Medication Solutions | 50090-1016 | 50090-1016-1 | 1 SYRINGE in 1 PACKAGE (50090-1016-1) / 2 mL in 1 SYRINGE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 600,000 UNITS/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | BC | RLD: | Yes | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 300,000 UNITS/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
